A Phase 2 Double-Blind, Placebo-Controlled, Randomized Dose Finding Study For The Efficacy And Safety Of Aminopterin In Methotrexate-Naive Rheumatoid Arthritis
Phase of Trial: Phase II
Latest Information Update: 22 May 2015
At a glance
- Drugs Aminopterin (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Syntrix Biosystems
- 19 May 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 28 Jul 2014 Planned End Date changed from 1 Oct 2014 to 1 Nov 2014 as reported by ClinicalTrials.gov.
- 28 Jul 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.